SUNGEN BIOTECH CO LTD
Sungen Biotech Co., Ltd. (SungenBio) is a high-tech Sino-US joint-venture, established in 2002 and located in Santou Free Trade Zone, China, and occupies 10 acres of Sungen Biotech Park. The current net asset is over ￥100M.
SungenBio focuses on R&D, manufacturing,and marketing botanical extracts, cardiovascular medicines, and anti-cancer medicines.
For natural botanical extracts, SungenBio integrates botanical extract resources and primary extracting factories in China, and cooperates closely each other with its intensive and advanced technologies to supply various natural botanical extracts, such as Icariin, EGCG, Resveratrol, Licorice Extract ect..., with stable quality and reasonable prices in "CephaGreenTM" brand meeting the regulations of pesticide residues, solvent residues and heavy metal contents for international markets, and produces and markets end products in "iHealthTM" brand made of those natural extracts with safety, efficacy and high availability.
For cardiovascular medicines, SungenBio puts efforts to promote "Extra-NattoTM" nattokinase products on market, and cooperates with Peking University in R&D of oral antithrombotics OralrudinTM (rHirudin) under China invention patent number: ZL03109244.6.
For anti-cancer medicines, SungenBio has employed R&D for manufacturing Paclitaxel Fungxol© by 4th generation technology of fungi fermentation, which international invention patents(WO 2006/009518)are under publication. And AlternolTM is a new molecular entity invented by SungenBio who has applied the international patent with registered number WO2006/036131 A1, and China patent number: ZL200510105664.5. The project has been listed as 2009 China Significant Innovative Project of National Anti-Cancer Medicine.
|HOME|ABOUT|PRODUCTS|QUALITY SYSTEM|R & D|PHILOSOPHY|NEWS|AGENT|SERVICE|CONTACT|
|SUNGEN BIOTECH COMPANY LIMITED
ADD: Sungen Bioteck Park,Free Trade Zone,Shantou,Guangdong,China